Related Experiment Video
Updated: May 23, 2026
11:17
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Off-label drug use in paediatrics: a world-wide problem
1Institutional Review Board, Ulm University, Institute for History, Theory & Ethics of Medicine, Frauensteige 6, D-89075 Ulm, Germany. christian.lenk@uni-ulm.de
Current Drug Targets
|April 20, 2012
Summary
Despite decades of effort, safe and effective paediatric drug use remains a challenge due to knowledge gaps and persistent ethical, legal, and regulatory issues in paediatric medication.
Area of Science:
- Medical Science
- Pharmacology
- Pediatrics
Background:
- Off-label drug use in children has been a persistent issue for over 35 years.
- International efforts aim to provide safe, effective, and well-documented medications for paediatric populations.
Purpose of the Study:
- To analyze the persistent obstacles in supplying children and adolescents with safe and effective medications.
- To provide an overview of current difficulties in paediatric off-label medication, focusing on ethical and regulatory aspects.
Main Methods:
- Analysis of the problem of off-label drug use in paediatrics.
- Review of ethical, legal, medical, pharmacological, and political practices.
Main Results:
- Significant obstacles remain despite extensive efforts by medical professionals and policymakers.
- A lack of medical knowledge and weaknesses in surrounding practices hinder optimal paediatric drug supply.
Conclusions:
- Persistent challenges in paediatric off-label medication require addressing knowledge gaps and improving ethical, legal, and regulatory frameworks.
- Further research and policy development are crucial for ensuring safe and effective drug use in children.
Related Concept Videos
01:02Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...